Menu
US
Case Study

Re-tooling anti-microbial research for the 21st century

retooling-anti-microbial512x288

Antimicrobial resistance (AMR) is one of today’s major global public health challenges. Recently, there has been renewed investment in the discovery of novel antimicrobials to urgently address the growing number of drug-resistant infections. This case study describes how Professor Gordon Dougan and his team at the Cambridge Biomedical Research Centre are using high-content analysis to phenotype individual bacteria within a population to investigate adaptive mechanisms of antimicrobial resistance, and to screen for novel alternatives to existing antimicrobials.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Re-tooling anti-microbial research for the 21st century

Download Case Study